Ida Grundberg
Chief Tech/Sci/R&D Officer at OLINK HOLDING AB
Profile
Ida Grundberg is currently the Chief Scientific Officer at Olink Holding AB since 2019.
Prior to this, she worked at Olink Proteomics AB from 2011 to 2019 as the Head of Business Development, VP of Sales & Marketing.
She obtained a doctorate degree from the University of Uppsala and completed her undergraduate and graduate studies at Umea Universitet.
Ida Grundberg active positions
| Companies | Position | Start |
|---|---|---|
| OLINK HOLDING AB | Chief Tech/Sci/R&D Officer | 2019-08-31 |
Former positions of Ida Grundberg
| Companies | Position | End |
|---|---|---|
Olink Proteomics AB
 Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Sales & Marketing | 2019-08-31 |
Training of Ida Grundberg
| University of Uppsala | Doctorate Degree |
| Umea Universitet | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OLINK HOLDING AB | Health Technology |
| Private companies | 1 |
|---|---|
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Ida Grundberg
